Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder (2012)
- Authors:
- USP affiliated authors: PEREIRA, CARLOS ALBERTO DE BRAGANCA - IME ; MIGUEL FILHO, EURIPEDES CONSTANTINO - FM
- Unidades: IME; FM
- Assunto: PSIQUIATRIA BIOLÓGICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Biological Psychiatry
- ISSN: 0006-3223
- Volume/Número/Paginação/Ano: v. 71, n. 8, Supplement, 56S-56S, Meeting Abstract 185, 2012
- Conference titles: Meeting Abstract: Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, 67
-
ABNT
DINIZ, Juliana Belo et al. Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder. Biological Psychiatry. New York: Instituto de Matemática e Estatística, Universidade de São Paulo. . Acesso em: 02 out. 2024. , 2012 -
APA
Diniz, J. B., Pereira, C. A. de B., Costa, D., Shavitt, R. G., & Miguel, E. C. (2012). Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder. Biological Psychiatry. New York: Instituto de Matemática e Estatística, Universidade de São Paulo. -
NLM
Diniz JB, Pereira CA de B, Costa D, Shavitt RG, Miguel EC. Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder. Biological Psychiatry. 2012 ; 71( 8):[citado 2024 out. 02 ] -
Vancouver
Diniz JB, Pereira CA de B, Costa D, Shavitt RG, Miguel EC. Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder. Biological Psychiatry. 2012 ; 71( 8):[citado 2024 out. 02 ] - Association study between the-62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder
- The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder
- Notice of Retraction and Replacement. Lopes et al. Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized [Carta]
- Quetotaxia dorsal e tagmatização em actinotrichida (Acariformes)
- Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder
- Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive–compulsive disorder
- A double-blind randomized controlled trial of fluoxetine plus quetiapine or clomipramine vs. Fluoxetine plus placebo for obsessive-compulsive disorder
- Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas